Evidence map›Paper›PMID 19303871›Full record

ArticleExperimental parasitology2009

Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.

Rubén E Varela M, Diana Lorena Muñoz, Sara M Robledo, Bala K Kolli, Sujoy Dutta, Kwang Poo Chang, Carlos Muskus

Open access · greenAbstract read
In one paragraph

Article in Experimental parasitology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Reporter gene systems: A powerful tool forCurrent research in microbial sciences · 2022
    Article
  3. Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection.International journal for parasitology. Drugs and drug resistance · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rubén E Varela MPrograma de Estudio y Control de Enfermedades Tropicales-PECET, Universidad de Antioquia, Calle 62 No 52-59, Lab. 632, Medellín, Colombia.
Diana Lorena Muñoz
Sara M Robledo
Bala K Kolli
Sujoy Dutta
Kwang Poo Chang
Carlos Muskus
Universidad de Antioquia · CORosalind Franklin University of Medicine and Science · US

Funding

LEISHMANIA/MACROPHAGE CELLULAR INTERACTIONS IN VITROR01AI020486 · NIAID · ROSALIND FRANKLIN UNIV OF MEDICINE &SCI · PI CHANG, KWANG-POO · 1986 to 2005
$1.1M
NIAID NIH HHS AI-20486NIAID NIH HHS R01 AI020486
6 · The paper itself

Abstract

Promastigotes of Leishmania (Viannia) panamensis were successfully transfected with p6.5-egfp to express green fluorescent protein. The transfectants remained infective to macrophages, providing an in vitro model for screening antileishmanial drugs. This was demonstrated by flow cytometry of macrophage-associated GFP after exposure of infected cultures to known antileishmanial drugs, i.e. amphotericin B and glucantime. Fluorescence of GFP diminished progressively from infected cells with increasing drug concentrations used in both cases. The availability of this fluorescent assay for infection of macrophages by L. (V.) panamensis facilitates drug discovery program for the Viannia species, which differ significantly from those of the Leishmania subgenus.

Indexed as

Amphotericin BAnimalsAntiprotozoal AgentsFlow CytometryGene ExpressionGreen Fluorescent ProteinsHumansLeishmania guyanensisLuminescent AgentsMacrophagesMeglumineMeglumine AntimoniateMicroscopy, FluorescenceMicroscopy, Phase-ContrastOrganometallic CompoundsTransfectionAmphotericin BAntiprotozoal AgentsGreen Fluorescent ProteinsLuminescent AgentsMeglumineMeglumine AntimoniateOrganometallic Compounds

Identifiers

PMID19303871
PMCPMC3640980
OpenAlexW2004163475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.